Theravance Biopharma, Inc. Business Finance Contracts & Agreements

24 Contracts & Agreements
Browse by Subcategory
Recent Contracts
Category
Company
Industry
Jur. Jurisdiction
Filed
Release Agreement among Innoviva, Inc., Innoviva TRC Holdings LLC, Royalty Pharma Investments 2019 ICAV, Theravance Respiratory Company, LLC, Theravance Biopharma, Inc.,...
Release Agreements
Theravance Biopharma, Inc.
Pharmaceuticals
NY
2022
Underwriting Agreement between Theravance Biopharma, Inc. and Underwriters for Sale of Ordinary Shares (June 24, 2021)
Underwriting Agreements
Theravance Biopharma, Inc.
Pharmaceuticals
NY
2021
Note Purchase Agreement among Theravance Biopharma R&D, Inc., Triple Royalty Sub II LLC, and Purchaser for $400 Million 9.5% Fixed Rate Term Notes Due 2035
Note Agreements
Theravance Biopharma, Inc.
Pharmaceuticals
DE
2020
Theravance Biopharma, Inc. Underwriting Agreement for 5,500,000 Ordinary Shares with Morgan Stanley, J.P. Morgan, and Cowen
Underwriting Agreements
Theravance Biopharma, Inc.
Pharmaceuticals
NY
2020
Agreement and General Release between Theravance Biopharma US, Inc. and Shehnaaz Suliman, dated March 1, 2019
Release Agreements
Theravance Biopharma, Inc.
Pharmaceuticals
CA
2019
Note Purchase Agreement among Theravance Biopharma R&D, Inc., Triple Royalty Sub LLC, and Purchasers (2018)
Note Agreements
Theravance Biopharma, Inc.
Pharmaceuticals
DE
2018
Asset Purchase Agreement between Cumberland Pharmaceuticals Inc. and Theravance Biopharma Entities (November 1, 2018)
Purchase Agreements
Theravance Biopharma, Inc.
Pharmaceuticals
NY
2018
First Supplemental Indenture to 3.25% Convertible Senior Notes Due 2023 between Theravance Biopharma, Inc. and Wells Fargo Bank, N.A.
Indenture Agreements
Theravance Biopharma, Inc.
Pharmaceuticals
NY
2016
First Supplemental Indenture to 3.25% Convertible Senior Notes Due 2023 between Theravance Biopharma, Inc. and Wells Fargo Bank, N.A.
Indenture Agreements
Theravance Biopharma, Inc.
Pharmaceuticals
NY
2016
Indenture Agreement between Theravance Biopharma, Inc. and Wells Fargo Bank, National Association, dated November 2, 2016
Indenture Agreements
Theravance Biopharma, Inc.
Pharmaceuticals
NY
2016
Underwriting Agreement for $200,000,000 3.250% Convertible Senior Notes due 2023 between Theravance Biopharma, Inc. and Underwriters
Underwriting Agreements
Theravance Biopharma, Inc.
Pharmaceuticals
NY
2016
Underwriting Agreement for 3,850,000 Ordinary Shares of Theravance Biopharma, Inc. with Leerink Partners LLC and Evercore Group L.L.C.
Underwriting Agreements
Theravance Biopharma, Inc.
Pharmaceuticals
NY
2016
Underwriting Agreement between Theravance Biopharma, Inc. and Underwriters for Sale of Ordinary Shares (April 28, 2016)
Underwriting Agreements
Theravance Biopharma, Inc.
Pharmaceuticals
NY
2016
Ordinary Share Purchase Agreement between Theravance Biopharma, Inc. and Purchasers (October 26, 2015)
Purchase Agreements
Theravance Biopharma, Inc.
Pharmaceuticals
DE
2015
Consent to Assignment of Lease Agreement among ARE-901/951 Gateway Boulevard, LLC, Theravance, Inc., and Theravance Biopharma US, Inc.
Assignment Agreements
Theravance Biopharma, Inc.
Pharmaceuticals
2014
Consent to Assignment of Lease by ARE-901/951 Gateway Boulevard, LLC to Theravance, Inc. and Theravance Biopharma US, Inc.
Assignment Agreements
Theravance Biopharma, Inc.
Pharmaceuticals
2014
Equity Purchase and Funding Agreement between Theravance Biopharma, Inc. and Royalty Pharma Investments 2019 ICAV (July 13, 2022)
Purchase Agreements
Theravance Biopharma, Inc.
Pharmaceuticals
DE
2022
Waiver and Assignment of Registration Rights and Voting Agreement among GSK Finance (No.3) plc, Glaxo Group Limited, and Theravance Biopharma, Inc.
Registration Rights Agreements
Theravance Biopharma, Inc.
Pharmaceuticals
DE
2020
Registration Rights Agreement among Theravance Biopharma, Inc., GlaxoSmithKline plc, and GSK Finance (No.3) plc dated June 22, 2020
Registration Rights Agreements
Theravance Biopharma, Inc.
Pharmaceuticals
NY
2020
First Amendment to Registration Rights Agreement between Theravance Biopharma, Inc. and Glaxo Group Limited
Registration Rights Agreements
Theravance Biopharma, Inc.
Pharmaceuticals
DE
2020
Ordinary Share Purchase Agreement between Theravance Biopharma, Inc. and Glaxo Group Limited (GSK) dated March 14, 2016
Purchase Agreements
Theravance Biopharma, Inc.
Pharmaceuticals
DE
2016
Theravance Biopharma, Inc. 2013 Employee Share Purchase Plan – UK Addendum
Bonus & Incentive Agreements
Theravance Biopharma, Inc.
Pharmaceuticals
2016
Ordinary Share Purchase Agreement between Theravance Biopharma, Inc. and Glaxo Group Limited (GSK) dated October 7, 2015
Purchase Agreements
Theravance Biopharma, Inc.
Pharmaceuticals
DE
2015
Ordinary Share Purchase Agreement between Theravance Biopharma, Inc. and Mylan Inc. dated January 30, 2015
Purchase Agreements
Theravance Biopharma, Inc.
Pharmaceuticals
PA
2015